Cargando…
Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis—systematic review protocol
BACKGROUND: Erythema migrans represents an early cutaneous and most common manifestation of Lyme borreliosis. Recommendations regarding pharmacological agents, dose and duration of treatment are subject of intense debate. This review aims to explore differences in efficacy and safety between pharmac...
Autores principales: | Torbahn, Gabriel, Hofmann, Heidelore, Allert, Roman, Freitag, Michael H., Dersch, Rick, Fingerle, Volker, Sommer, Harriet, Motschall, Edith, Meerpohl, Jörg J., Schmucker, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855495/ https://www.ncbi.nlm.nih.gov/pubmed/27142846 http://dx.doi.org/10.1186/s13643-016-0251-3 |
Ejemplares similares
-
Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society
por: Hofmann, Heidelore, et al.
Publicado: (2017) -
Large erythema migrans lesion in Lyme disease
por: Takeuchi, Yuki
Publicado: (2020) -
Erythema Migrans-like Rash Mimicking Lyme Disease
por: Fukushima, Kazuaki, et al.
Publicado: (2019) -
Guidelines for diagnosis and treatment in neurology – Lyme neuroborreliosis
por: Rauer, Sebastian, et al.
Publicado: (2020) -
Serologically diagnosed Lyme disease manifesting erythema migrans in Korea.
por: Kim, T. H., et al.
Publicado: (1999)